AlphaQuest’s Cidara Therapeutics CDTX Stock Holding History

AlphaQuest’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,985	Closed	-$1.1M	–	370
2025 Q4	$1.1M	Buy	4,985 +178	+4%	+$28.8K	0.06%	405
2025 Q3	$460K	Sell	4,807 -103	-2%	-$6.57K	0.03%	845
2025 Q2	$239K	Buy	+4,910	New	+$118K	0.02%	1020

AlphaQuest's CDTX Position: Q1 2026 in Review

AlphaQuest sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 4,985 shares — an estimated $1.1M sold.

AlphaQuest first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $1.1M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

AlphaQuest reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 4,985 Cidara Therapeutics shares in Q1 2026, an estimated $1.1M.
AlphaQuest first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
AlphaQuest's Cidara Therapeutics position peaked at $1.1M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.